Skip to main content

previous disabled Page of 2
and
  1. No Access

    Chapter

    The Role of Department Chair

    The leadership position of a departmental chair can be a positive and rewarding opportunity. These rewards principally stem from the success of the faculty, trainees, staff, and everyone supporting the departm...

    Christopher G. Willett, Quynh-Thu Le in Career Development in Academic Radiation Oncology (2021)

  2. No Access

    Article

    Total Neoadjuvant Therapy (TNT) in Rectal Cancer

    This review summarizes the relevant literature on the use of total neoadjuvant therapy (TNT) for patients with locally advanced rectal cancer. It highlights the most notable literature published and briefly di...

    Sarah J. Stephens, Christopher G. Willett in Current Colorectal Cancer Reports (2018)

  3. No Access

    Chapter

    Anal Canal Cancer

    Radiation therapy with concurrent chemotherapy is the standard treatment for patients with nonmetastatic squamous cell carcinoma of the anal canal. In the studies that established this approach, high rates of ...

    Bradford A. Perez, Christopher G. Willett in Intensity-Modulated Radiation Therapy (2015)

  4. No Access

    Article

    Adjuvant chemotherapy for rectal cancer—an unresolved issue

    Several clinical trials have addressed the role of adjuvant chemotherapy following neoadjuvant chemoradiation and surgery for rectal cancer. The recently published EORTC 22921 study adds further debate to the ...

    Manisha Palta, Brian G. Czito, Christopher G. Willett in Nature Reviews Clinical Oncology (2014)

  5. Article

    Open Access

    Preoperative chemoradiotherapy for locally advanced gastric cancer

    To examine toxicity and outcomes for patients treated with preoperative chemoradiotherapy (CRT) for gastric cancer.

    Joseph M Pepek, Junzo P Chino, Christopher G Willett, Manisha Palta in Radiation Oncology (2013)

  6. No Access

    Article

    Potential Novel Drugs to Combine with Radiation in Rectal Cancer

    The management of rectal cancer has seen significant advances in surgery, radiation therapy, and chemotherapy in recent years. These advances have translated into improved rates of local and distant disease co...

    Brian G. Czito, Christopher G. Willett in Current Colorectal Cancer Reports (2012)

  7. No Access

    Chapter

    Esophageal Cancer

    Less than 15% of patients diagnosed with esophageal cancer are cured, with half of patients presenting with unresectable or metastatic disease. This chapter will review the natural history and treatment of eso...

    Brian G. Czito, Christopher G. Willett in Technical Basis of Radiation Therapy (2012)

  8. No Access

    Book

  9. No Access

    Chapter

    Recurrent Colorectal Cancer

    Aggressive, curative intent treatment approaches in patients with local or regional relapse after resection of primary rectal or colon cancers are often not considered. A growing body of evidence supports an a...

    Michael G. Haddock, Heidi Nelson, Vincenzo Valentini in Intraoperative Irradiation (2011)

  10. No Access

    Chapter

    Rationale and Historical Perspective of Intraoperative Irradiation

    Most of the major advances in clinical applications of radiation therapy in the treatment of cancer have been due to differences in dose distribution between tumor and dose-limiting normal tissue. For most tum...

    Leonard L. Gunderson, Felipe A. Calvo, Christopher G. Willett in Intraoperative Irradiation (2011)

  11. No Access

    Chapter

    Intraoperative Electron Beam Irradiation: Physics and Techniques

    Since IORT using electron beams first became popular in the late 1970s and early 1980s, enthusiasm for the technique using conventional accelerators waned. The reasons for this are manyfold. The main factor wa...

    Peter Biggs, Christopher G. Willett, Harm Rutten in Intraoperative Irradiation (2011)

  12. No Access

    Chapter

    Normal-Tissue Tolerance to IOERT, EBRT, or Both: Animal and Clinical Studies

    Early clinical investigations of intraoperative electron irradiation (IOERT) as an alternative to conventional external-beam irradiation (EBRT) were based on a limited number of preclinical studies to provide ...

    Zeljko Vujaskovic, Christopher G. Willett, Joel E. Tepper in Intraoperative Irradiation (2011)

  13. No Access

    Chapter

    Pancreas Cancer

    Despite its infrequency, pancreatic cancer is the fourth leading cause of cancer death in USA with an estimated 42,140 new cases and 36,800 deaths projected in the USA for 2010 [1]. Although mortality rates ha...

    Robert C. Miller, Vincenzo Valentini, Adyr Moss in Intraoperative Irradiation (2011)

  14. No Access

    Chapter

    Primary Colorectal Cancer

    Carcinoma of the rectum is a heterogeneous disease. At one end of the clinical spectrum, a small number of patients present with superficially invasive cancers who are well served by limited ­procedures, such ...

    Nils D. Arvold, Theodore S. Hong, Christopher G. Willett in Intraoperative Irradiation (2011)

  15. No Access

    Chapter

    Retroperitoneal Sarcomas

    Retroperitoneal sarcomas are rare, accounting for approximately 10–15% of all soft-tissue sarcomas with an estimated 1,500 cases occurring annually in USA [1, 2]. The most common histologic subtypes include li...

    Brian Czito, John Donohue, Christopher G. Willett in Intraoperative Irradiation (2011)

  16. No Access

    Chapter

    Conclusions and Future Possibilities: IORT

    Long-term experience has shown that the use of IORT as a component of treatment in conjunction with other modalities (EBRT, concurrent and maintenance chemotherapy, maximal surgical resection) is feasible and ...

    Leonard L. Gunderson, Christopher G. Willett, Felipe A. Calvo in Intraoperative Irradiation (2011)

  17. No Access

    Chapter

    IORT with Electron-Beam, High-Dose-Rate Brachytherapy or Low-KV/Electronic Brachytherapy: Methodological Comparisons

    Intraoperative irradiation (IORT) refers to delivery of a single dose of irradiation to a surgically exposed tumor or tumor bed while the normal tissues are protected from the irradiation either by retracting ...

    Subir Nag, Christopher G. Willett, Leonard L. Gunderson in Intraoperative Irradiation (2011)

  18. No Access

    Book

    Rectal Cancer

    International Perspectives on Multimodality Management

    Brian G. Czito, Christopher G. Willett in Current Clinical Oncology (2010)

  19. No Access

    Article

    Biomarkers of response and resistance to antiangiogenic therapy

    No validated biomarkers currently exist for appropriately selecting cancer patients for antiangiogenic therapy. A number of potential systemic, circulating, tissue and imaging biomarkers have emerged as suitab...

    Rakesh K. Jain, Dan G. Duda, Christopher G. Willett in Nature Reviews Clinical Oncology (2009)

  20. No Access

    Article

    Current management of anal canal cancer

    Squamous cell carcinoma of the anal canal historically has been treated with abdominoperineal resection, resulting in high rates of morbidity and local recurrence. Pioneering work led to the finding that radia...

    Brian G. Czito, Christopher G. Willett in Current Oncology Reports (2009)

previous disabled Page of 2